Zusammenfassung
Leitlinien sind Orientierungshilfen im Sinne von „Handlungs- und Entscheidungskorridoren“, von denen in begründeten Fällen abgewichen werden kann oder sogar muss. Sie beschreiben, was Augenärzte für eine angemessene Patientenversorgung in der Praxis für geboten halten. Dies entspricht in vielen Fällen nicht dem Leistungsniveau der gesetzlichen Krankenversicherung in Deutschland (s. Präambel).
Literatur
Newman RG et al (2013) The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. Immunol Res 57(1):125–139
Inamoto Y et al (2019) Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):648–661
Dietrich-Ntoukas T et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 31(3):299–310
Filipovich AH et al (2005) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945–956
Na KS et al (2015) Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50(11):1459–1464
Westekemper H et al (2017) Ocular graft versus host disease : corneal complications. Ophthalmologe 114(8):697–702
Giannaccare G et al (2019) Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol 257(7):1341–1351
Hu B, Qiu Y, Hong J (2020) Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD). Ocul Surf 18(2):298–304
Engel LA et al (2015) Meibography and meibomian gland measurements in ocular graft-versus-host disease. Bone Marrow Transplant 50(7):961–967. https://doi.org/10.1038/bmt.2015.72
Mirza N et al (2016) Graft versus self (GvS) against T‑cell autoantigens is a mechanism of graft-host interaction. Proc Natl Acad Sci U S A 113(48):13827–13832
Mohty M et al (2002) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 100(9):3128–3134
Steven P et al (2015) Semifluorinated alkane eye drops for treatment of dry eye disease—a prospective, multicenter noninterventional study. J Ocul Pharmacol Ther 31(8):498–503
Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12(5):540–547
Inamoto Y et al (2019) Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the late effects and quality of life working committee of the CIBMTR and transplant complications working party of the EBMT. Bone Marrow Transplant 54(5):662–673
Steven P et al (2020) Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55(9):1851–1853. https://doi.org/10.1038/s41409-020-0824-6
Espana EM et al (2013) Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol 251(5):1257–1266
Jabs DA et al (1989) The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 107(9):1343–1348
Jagasia MH et al (2015) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant 21(3):389–401.e1
Giannaccare G et al (2019) In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system. Graefes Arch Clin Exp Ophthalmol 257(3):583–589
Versura P et al (2013) Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. Cornea 32(4):412–418
Berchicci L et al (2014) Tear osmolarity in ocular graft-versus-host disease. Cornea 33(12):1252–1256
Schargus M et al (2015) Correlation between tear film osmolarity and the disease score of the international chronic ocular graft-versus-host-disease consensus group in hematopoietic stem cell transplantation patients. Cornea 34(8):911–916
Ban Y et al (2011) Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis 17:2533
He J et al (2017) In vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep 7(1):10720
Steger B et al (2015) In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. Br J Ophthalmol 99(2):160–165
Giannaccare G et al (2019) Corneal biomechanical alterations in patients with chronic ocular graft versus-host disease. PLoS One 14(4):e213117
Abud TB et al (2016) A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease. Ophthalmology 123(7):1449–1457
Dastjerdi MH, Hamrah P, Dana R (2009) High-frequency topical cyclosporine 0.05 % in the treatment of severe dry eye refractory to twice-daily regimen. Cornea 28(10):1091–1096
Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05 % cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213–225
Dignan FL et al (2012) Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol 158(1):62–78
Ervin AM, Law A, Pucker AD (2019) Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review. Br J Ophthalmol 103(3):301–306
Sabti S et al (2012) Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant 47(7):981–984
Jacobs DS, Rosenthal P (2007) Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 26(10):1195–1199
Stoyanova EI et al (2015) Bandage and scleral contact lenses for ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Acta Ophthalmol 93(7):e604. https://doi.org/10.1111/aos.12711
Ogawa Y et al (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31(7):579–583
Tahmaz V et al (2017) Treatment of severe chronic ocular graft-versus-host disease using 100 % autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br J Ophthalmol 101(3):322–326
Inagaki E et al (2011) Four cases of corneal perforation in patients with chronic graft-versus-host disease. Mol Vis 17:598–606
Yeh PT et al (2006) Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. J Formos Med Assoc 105(4):334–339
Peris-Martinez C et al (2001) Multilayer amniotic membrane transplantation in severe ocular graft versus host disease. Eur J Ophthalmol 11(2):183–186
Shah A, Santhiago MR, Espana EM (2016) Cataract surgery in patients with chronic severe graft-versus-host disease. J Cataract Refract Surg 42(6):833–839
Claessens D, Schuster AK (2019) Correlation of Quantitative Metamorphopsia Measurement and Central Retinal Thickness in Diabetic Macular Edema and Age-Related Exsudative Macular Degeneration. Klin Monbl Augenheilkd 236(7):877–884. https://doi.org/10.1055/s-0043-125080. Epub 2018 Feb 28
Redaktionskomitee
Bertram, Bernd; Claessens, Daniela; Cursiefen, Claus; Dietrich-Ntoukas, Tina; Eberwein, Philipp; Ostrowski, Angelika; Seitz, Berthold; Steven, Philipp; Uhlig, Constantin; Westekemper, Henrike
Author information
Authors and Affiliations
Consortia
Ethics declarations
Interessenkonflikt
Siehe Tab. 4 im Anhang.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
The supplement containing this article is not sponsored by industry.
Additional information
Das Redaktionskomitee dieser Stellungnahme wird am Beitragsende gelistet.
AWMF-Register-Nr. 045-017
Versions-Nummer: 1.1
Erstveröffentlichung: 06/2020
Nächste Überprüfung geplant: 06/2025
Hier aufgeführte, im Leitlinienreport bzw. den Evidenztabellen jedoch nicht enthaltene Publikationen sind expertenbeigesteuert (s. Leitlinienreport).
QR-Code scannen & Beitrag online lesen
Anhang
Anhang
Tabelle zur Erklärung von Interessen und Umgang mit Interessenkonflikten
Im Folgenden sind die Interessenerklärungen als tabellarische Zusammenfassung dargestellt sowie die Ergebnisse der Interessenkonfliktbewertung und Maßnahmen, die nach Diskussion der Sachverhalte von der der LL-Gruppe beschlossen und im Rahmen der Konsensuskonferenz umgesetzt wurden (Tab. 4).
Rights and permissions
About this article
Cite this article
Deutsche Ophthalmologische Gesellschaft (DOG)., Berufsverband der Augenärzte Deutschlands e. V. (BVA). Okuläre Graft-Versus-Host Erkrankung. Ophthalmologie 120 (Suppl 1), 50–58 (2023). https://doi.org/10.1007/s00347-022-01781-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-022-01781-6